Search results for Pharmaceutical Companies

Pharma Companies Invest In US While India Still Depends On China For APIs

“For decades, India built its reputation as the “pharmacy of the world” by manufacturing low-cost generic medicines that reached millions across Africa, Latin America, and Asia. Bu...

2 more drug companies to officially launch on TrumpRx

Two more drug-making giants, Abbvie and Genentech, will start selling popular medications on the White House's discounted pharmaceutical site as soon as Monday.

All Major Pharma Companies Implicated in Bribery Schemes, New Report Says

Pfizer, J&J, Eli Lilly, BMS, AstraZeneca, GSK, and more all engaged in systematic bribery schemes, according to decades of OECD reports. That’s the finding of a bombshell new s...

<![CDATA[Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement]]>

<![CDATA[Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report ]]&g...

<![CDATA[What's Driving the Concentration of Blockbuster Drugs]]>

Pharma industry should reduce dependence on import of raw materials: Rajesh Agarwal

Indian companies should identify and deepen their presence in markets with stronger export potential in order to protect and further expand the country’s $60-billion pharmaceutical...

US Investments Intended To Take Indian Pharma Up The Value Chain: Interview

This is the first time such huge investments are being made. The Indian pharmaceutical industry has grown from small companies into multinational corporations. Out of the top 20 gl...

<![CDATA[Pharmaceutical Executive Daily: Angelini Pharma Acquires Catalyst Pharmaceuticals in $4.1 Billion Agreement]...

Top 10 Pharmaceutical Sectors Set to Boom (2026–2031)

The pharmaceutical industry is entering a new era of hyper-growth, specifically within subsectors powered by next-generation biological and genetic engineering. These fields are cu...

<![CDATA[Model Examples]]>

<![CDATA[Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson &...

Drug Amount Reporting: FDA Publicly Identifies over 7,700 Noncompliant Companies

By Fabiola C. Gomez, Ph.D., CMC Regulatory Expert —

Pharmaceutical sector grows by 50pc

ZIMBABWE’S phar­maceutical sector has expanded by 50 percent since 2021, with the number of local manufacturers rising from 10 to 15. The... To access this content, plea...

Pharma's Deal Boom Is Fueling Demand for M&A Lawyers

Many large pharmaceutical companies are increasingly turning to acquisitions rather than relying solely on internal research and development efforts to build their drug pipelines....

<![CDATA[Angelini Pharma Enters $ 4.1 Billion Agreement to Acquire Catalyst Pharmaceuticals ]]>

<![CDATA[Capital Gains]]>

<![CDATA[Pharma M&A Roundup: Bayer to Acquire Perfuse Therapeutics, Madrigal Enters Licensing Agreement for ARO-P...

Research Reveals Pharma Profits Outweigh Anti-Kickback Penalties

The pharmaceutical industry has a well documented history of corruption and placing profit above public health. A new research letter published in JAMA Open finds that US revenues...

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics]]>

<![CDATA[Maximizing Drug Impact]]>

<![CDATA[Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu]]>

<![CDATA[Johnson & Johnson’s Experience Navigating The Commissioner’s National Priority Voucher Program]]>

<![CDATA[Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics ]]>